Table 2 Univariate associations between comorbidity and ACE inhibitor therapy.
Comorbidity | ACE inhibitor non- users n (%) | ACE inhibitor users n (%) | Odds Ratio | P |
|---|---|---|---|---|
Rheumatic disease | 80 (14.3) | 62 (13.9) | 0.97 | 0.86 |
Asthma/COPD | 116 (20.8) | 87 (19.6) | 0.93 | 0.63 |
CAD | 98 (17.6) | 95 (21.4) | 1.27 | 0.13 |
Cancer | 82 (14.7) | 44 (9.9) | 0.64 | 0.02 |
CHF | 87 (15.6) | 85 (19.1) | 1.28 | 0.14 |
Cirrhosis | 9 (1.6) | 9 (2.0) | 1.26 | 0.63 |
CVA | 70 (12.5) | 48 (10.8) | 0.84 | 0.39 |
Depression | 198 (35.5) | 153 (34.4) | 0.95 | 0.72 |
Paresis | 17 (3.1) | 13 (2.9) | 0.96 | 0.91 |
PUD | 90 (16.1) | 53 (11.9) | 0.70 | 0.06 |
PVD | 45 (8.1) | 43 (9.7) | 1.22 | 0.38 |